-
1دورية أكاديميةAflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
المؤلفون: Alsaedi NG, Alselaimy RM, Alshamrani AA, AlAjmi M, Khandekar R, Al-Dhibi H, Al-Abdullah AA
المصدر: Clinical Ophthalmology, Vol Volume 15, Pp 2975-2980 (2021)
مصطلحات موضوعية: aflibercept, bevacizumab, persistent dme, ranibizumab, vegf switch, vascular endothelial growth factor, Ophthalmology, RE1-994
وصف الملف: electronic resource